Perspectives on 2015 Drug and Treatment Approvals

被引:0
作者
Mohundro, Michael M. [1 ]
机构
[1] Our Lady Lake Reg Med Ctr, Pharm, Baton Rouge, LA USA
关键词
CARDIOVASCULAR EVENTS; REDUCING LIPIDS; HEART-FAILURE; NEPRILYSIN; INHIBITION; EFFICACY; SAFETY;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:5 / 8
页数:4
相关论文
共 21 条
  • [1] [Anonymous], 2015, PHARM APPROVALS 0317
  • [2] [Anonymous], 2015, SAV PRESCR INF
  • [3] [Anonymous], 2014, OPD PRESCR INF
  • [4] [Anonymous], 2015, FDA POSTP ADV COMM R
  • [5] [Anonymous], CHOLB CHOL AC
  • [6] [Anonymous], 2014, ONCLIVE 0129
  • [7] [Anonymous], COS SEC
  • [8] [Anonymous], 2015, NOV NEW DRUGS 2014 S
  • [9] [Anonymous], 2014, BIOL BIOS OV
  • [10] [Anonymous], 2015, POSTP ARTHR ADV COMM